| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.26 | 5e-10 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-08 |